DRDennis Rottländer

Dennis Rottländer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dennis Rottländer has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Residual Mitral Regurgitation as a Long-Term Predictor of Mortality After Mitral TEER

    by Dennis Rottländer, Taoufik Ouarrak, Jörg Hausleiter, Thomas Schmitz, Alexander Bufe, Melchior Seyfarth, Harald Beucher, Steffen Schneider, Peter Boekstegers


  • Open Access

    Clinical Vulnerability Refines Rhythm‐Related Outcomes in Older Patients Undergoing Pulmonary Vein Isolation for Atrial Fibrillation: An Observational Cohort Study

    by Yazan Mohsen, Jascha Fernholz, Lucas Steffens, Iryna Novikov, Shreeram Sabareesan, Ishan Vatsaraj, Kensuke Sakata, Moritz Knitter, Henning Horlitz, Marc Horlitz, et al.

    Introduction: Chronological age is often considered when selecting patients for atrial fibrillation (AF) ablation, but age alone may not identify which older patients are most likely to require recurrent rhythm‐related care after pulmonary vein isolation (PVI). Methods: We conducted a single‐center observational study of consecutive patients undergoing PVI. The principal registry cohort assessed the same‐center recurrence‐related rhythm‐intervention endpoint, defined as the first post‐index repeat PVI or electrical cardioversion. A nested active 2022 cohort assessed broader actively ascertained recurrence. Age was analyzed as < 50, 50–74, and ≥ 75. An exploratory elderly vulnerability score assigned one point each for documented persistent AF, heart failure, chronic kidney disease, and valve disease/surgery. Results: The registry cohort included 2559 patients and 580 same‐center rhythm‐intervention events. Event rates increased across age groups: 14.2% in patients aged < 50, 20.8% in those aged 50–74, and 29.8% in those aged ≥ 75. Age ≥ 75 was independently associated with higher risk versus age 50–74 in adjusted registry Cox analysis, HR: 1.35, 95% CI: 1.12–1.64, p = 0.002, after 90‐day blanking, HR: 1.37, 95% CI: 1.12–1.69, p = 0.002, and in the active cohort, HR: 1.46, 95% CI: 1.01–2.11, p = 0.042. Elderly Score 0 patients were not significantly different from patients aged 50–74 in registry analysis, aHR: 1.13, 95% CI: 0.79–1.63, p = 0.5, or active analysis, aHR: 1.01, 95% CI: 0.49–2.09, p = 0.975, whereas Score ≥ 2 identified higher event burden in both the registry cohort, aHR: 1.85, 95% CI: 1.45–2.35, p < 0.001, and active cohort, aHR: 1.95, 95% CI: 1.23–3.12, p = 0.005. Conclusion: Age ≥ 75 was associated with a higher rate of same‐center recurrence‐related rhythm interventions after PVI, but the risk varied substantially. Clinical vulnerability, not chronological age alone, may better inform counseling and selection of older patients.

  • Open Access

    Instantaneous Wave-Free Ratio for Evaluation of Circumflex Artery Compression During Indirect Mitral Annuloplasty

    by Dennis Rottländer, Milad Golabkesh, Hubertus Degen, Dimitrios Barlagiannis, Alev Ögütcü, Martin Saal, Michael Haude

  • Nutzen der CT-basierten Messung der koronaren Flussreserve im Rahmen der Ambulantisierung der kardialen CT in Deutschland – eine Propensity Score Matched Analyse

    by Dennis Rottländer, Cara Fischer, Yazan Mohsen, Melchior Seyfarth, Marc Horlitz, Paul Martin Bansmann

    Zusammenfassung: Die koronare Herzkrankheit (KHK) bleibt eine der führenden Todesursachen in Deutschland. Mit der seit 2024 möglichen ambulanten Abrechnung der koronaren Computertomografie-Angiografie (CCTA) gewinnt die nicht-invasive Diagnostik an Bedeutung. Die CT-basierte fraktionelle Flussreserve (FFR-CT) könnte die Spezifität der CCTA erhöhen und invasive Eingriffe reduzieren. In einer retrospektiven Analyse wurden 640 konsekutive Patienten mit Koronarstenosen >25% im ambulanten CCTA eingeschlossen. Bei 107 Patienten erfolgte zusätzlich eine FFR-CT. Nach Propensity-Score-Matching standen zwei Kohorten mit jeweils 105 Patienten für den Vergleich zur Verfügung. Primärer Endpunkt der Studie war der Vergleich der diagnostischen Genauigkeit von CCTA mit und ohne FFR-CT anhand des positiven prädiktiven Werts gegenüber der invasiven Koronarangiografie. Die FFR-CT zeigte nach Propensity-Score-Matching einen PPV von 88%, verglichen mit 73% in der Gruppe ohne FFR-CT. Patienten mit unauffälliger FFR-CT wurden überwiegend konservativ behandelt, während pathologische Werte in mehr als 70% zu Revaskularisation führten. In der Kontrollgruppe ohne FFR-CT ergaben sich deutlich häufiger invasive Herzkatheteruntersuchungen ohne Notwendigkeit der Koronarintervention (27%). Die Korrelation zwischen FFR-CT und invasiver FFR war hoch (r = 0,92; ICC = 0,95). Die Integration der FFR-CT in die ambulante CCTA kann potenziell die diagnostische Genauigkeit erhöhen und Herzkatheteruntersuchungen reduzieren. Sie bietet die Möglichkeit, anatomische und funktionelle Information zu kombinieren und Therapieentscheidungen bei stabiler KHK zu optimieren.

  • Open Access

    Impact of Left Atrial v‐Wave Following Mitral Edge‐to‐Edge Repair on Survival: The MITRA‐PRO Registry

    by Dennis Rottländer, Jörg Hausleiter, Thomas Schmitz, Alexander Bufe, Melchior Seyfarth, Ralph S. von Bardeleben, Harald Beucher, Taoufik Ouarrak, Steffen Schneider, Peter Boekstegers

    Background: Transcatheter edge‐to‐edge repair (TEER) for mitral regurgitation has been shown to affect left atrial pressure (LAP). However, the prognostic significance of postprocedural LAP changes remains a matter of debate. We aimed to evaluate the impact of v‐wave on long‐term survival after TEER. Methods: A total of 1487 patients in the large‐scale, multicenter MITRA‐PRO (MITRAclip PROgnosis) registry with post–mitral TEER v‐wave assessment were included in this study. Results: After 3‐years, survival was significantly reduced in patients with increased v‐wave after mitral TEER, while patients with decreased v‐wave showed the lowest 3‐year mortality. A receiver operating characteristic analysis revealed a postprocedural v‐wave >25 mm Hg as a relevant predictor of 3‐year mortality following mitral TEER. Three‐year mortality was significantly lower in patients with a v‐wave ≤25 mm Hg indicating a postprocedural v‐wave >25 mm Hg as a negative predictor of long‐term survival (v‐wave ≤25 mm Hg group: 34.2% versus v‐wave >25 mm Hg group: 46.8%; P 25 mm Hg: New York Heart Association I: 11.3%, II: 32.3, III: 47.6%, and IV: 8.9%; P =0.003). In both, functional and degenerative mitral regurgitation 3‐year mortality was significantly higher in the v‐wave >25 mm Hg group. Conclusions: A postprocedural v‐wave >25 mm Hg is linked to reduced long‐term survival. Multimodal residual mitral regurgitation assessment including v‐wave supports the interventionalist in TEER guidance and optimizing procedural results aiming for decreasing v‐wave to <25 mm Hg. Registration: URL: https://drks.de/search/en/trial/DRKS00012288 ; German Clinical Trials Register identifier: DRKS00012288.


  • Open Access

    Residual Mitral Regurgitation After Transcatheter Edge-to-Edge Repair Worsens Survival in Patients with Renal Dysfunction

    by Dennis Rottländer, Jörg Hausleiter, Thomas Schmitz, Alexander Bufe, Melchior Seyfarth, Harald Beucher, Taoufik Ouarrak, Steffen Schneider, Peter Boekstegers

  • Residual Mitral Regurgitation Outweighs Mean Pressure Gradient in Predicting Long‐Term Survival After Transcatheter Edge‐to‐Edge Repair Across Mitral Regurgitation Etiologies

    by Dennis Rottländer, Jörg Hausleiter, Thomas Schmitz, Alexander Bufe, Melchior Seyfarth, Harald Beucher, Taoufik Ouarrak, Steffen Schneider, Peter Boekstegers

    Background: The influence of elevated mitral mean pressure gradient (MPG) following transcatheter edge‐to‐edge repair (TEER) on survival across mitral regurgitation (MR) etiologies is controversial. Aims: To evaluate the impact of MPG and residual MR on survival following TEER. Methods: In the MITRA‐PRO registry survival was assessed three years after mitral TEER for patients with functional (FMR) or degenerative mitral regurgitation (DMR) and MPG < 5 mmHg or ≥ 5 mmHg in the presence or absence of relevant residual MR. Results: In the MPG < 5 mmHg group 720 patients with FMR were included (57.4%), while 125 patients with MPG ≥ 5 mmHg had FMR (54.1%). 358 patients were identified with MPG < 5 mmHg and 70 patients with MPG ≥ 5 mmHg (16.4%) post TEER in DMR. Only 11 patients had MPG ≥ 7 mmHg. In both FMR and DMR 3‐year mortality was not significantly higher in the MPG ≥ 5 mmHg group compared to MPG < 5 mmHg. An analysis with MPG groups (5 mmHg) demonstrated no increment in 3‐year mortality over MPG groups for FMR and DMR. For both groups, residual MR was the main predictor of 3‐year mortality, while elevated MPG did not negatively affect survival. Independent of MR entity, the lowest mortality was found without relevant residual MR. In atrial functional MR 3‐year mortality was also comparable between MPG < 5 and MPG ≥ 5 mmHg. Conclusions: An increased MPG of 5–6 mmHg in patients without relevant residual MR did not lead to an increased mortality rate across all MR entities, demonstrating the pivotal role of residual MR for survival following TEER. Trial Registration: DRKS00012288.


  • Open Access

    Comparison of specialised outpatient palliative care in heart failure and cancer patients: a German cross-sectional study

    by Dennis Rottländer, Marie-Therese Schmitz, Ulrich Grabenhorst, Klaus Weckbecker, Johannes Maximilian Just

    Objectives Specialised outpatient palliative care (SOPC) is an important element of the palliative care concept in Germany. The aim of this study is to compare patient characteristics, care processes and outcomes of patients with heart failure (HF) and oncological diseases, using the latter as a reference group to identify disease-specific needs and support the adaptation of SOPC to non-oncological conditions such as HF. Design, setting and interventions In this cross-sectional study (22 SOPC providers), clinical data of all palliative care patients who were treated between 2017 and 2021 were retrospectively analysed. Primary and secondary outcome measures Survival was estimated by Kaplan-Meier analysis. To further examine the relationship between patient survival time and various variables, a Cox proportional hazards model was used. Differences in symptom burden were tested for statistical significance using the McNemar test. Participants Data from 48 882 patients were analysed, with 5387 (11.0%) identified as having a primary HF diagnosis. This cohort was compared against a large oncological group consisting of 34 287 (70.1%) patients. Results For HF patients, the mean number of days spent in SOPC was 30.5±67.7 days and for oncological patients 44.1±72.0 days. A significantly higher proportion of oncological patients died in hospices (14.0%) and hospitals (6.9%) compared with HF (2.9% and 2.2%). Age-adjusted Charlson Comorbidity Index at admission into SOPC was 9.4±3.1 in oncological patients compared with 6.7±1.7 in HF (pConclusions HF patients in SOPC exhibit a different clinical profile compared with oncological patients, characterised by significant symptom burden and shorter survival times. These results emphasise the necessity for tailored palliative interventions to address the specific needs of HF patients.


  • Open Access

    CT angiography-derived three-dimensional pulmonary vein topography is related to the outcome after cryoballoon ablation

    by Martin Saal, Annika Esser, Torsten Becker, Florian Stöckigt, Yazan Mohsen, Marc Horlitz, Michael Haude, Dennis Rottländer

    Background: Following cryoballoon ablation, 20%–30% of the patients show recurrent atrial fibrillation (AF) in long-term follow-up as a consequence of incomplete circumferential ablation lines. Patient selection using computer tomography angiography (CTA)-derived parameters might be feasible to assign patients for cryoballoon ablation according to pulmonary vein (PV) anatomy and topography.Methods: We aimed to analyze the impact of anatomical and topographic PV parameters on the procedural outcome of cryoballoon PVI using a retrospective analysis of 106 patients with paroxysmal AF and preprocedural CTA.Results: Clinical follow-up of the study cohort revealed 78 patients (73.6%, PVI success group) without and 28 patients (26.4%, PVI failure group) with recurrent AF 12 months after cryoablation. Anatomical measurements such as PV diameter, PV area, PV perimeter, or PV eccentricity were not associated with procedural success. The number of occlusion attempts in the right inferior PV was significantly higher in the PVI failure group indicating a technical more complex balloon occlusion. The septum angle α (septum–PV) was significantly lower in the superior PVs of the PVI failure group indicating a direct relation of transseptal puncture site to procedural success. Furthermore, orifice angle β (PV orifice–PV course) was increased and intra-atrial angle γ (septum–PV course) was decreased in the inferior PVs of the PVI failure group.Conclusion: Patient selection using CTA prior to cryoballoon ablation might influence the procedural success of cryoballoon PVI. While PV anatomy in regard to vein size and shape was not associated with procedural outcome, septum, orifice, and intra-atrial angulation were related to procedural success.

  • Impact of Intraprocedural Residual Mitral Regurgitation on Long-Term Survival

    by Dennis Rottländer, Jörg Hausleiter, Thomas Schmitz, Alexander Bufe, Melchior Seyfarth, Ralph Stephan von Bardeleben, Harald Beucher, Taoufik Ouarrak, Steffen Schneider, Peter Boekstegers